Cancer
Dartmouth Cancer Center expands program that provides protected research time for clinician-scientists
Dartmouth Health has renewed its successful Cancer Faculty Fellows program. More than $1M annually to be distributed to selected oncology clinicians will allow them up to 2 days a week for dedicated cancer research.
Coping through the emotional impact of cancer treatment and beyond
Clinical health psychologist, Sivan Rotenberg, PhD, presents ways to cope with the ups and downs of cancer treatment and into survivorship.
Precision cancer prevention research and innovation
Precision prevention means developing tools to map each person’s individual risk factors for cancer, and creating bold new strategies to reduce those risks.
Dartmouth Cancer Center announces Complementary Care Program
Dartmouth Cancer Center’s Patient and Family Support Services is now the Complementary Care Program, providing services free of charge to current and former patients and their care partners.
This Colorectal Cancer Awareness Month, Learn About the Best Prevention, Screening Methods from D-H Experts
“The Importance of Screening for Colorectal Cancer” will be held on Tuesday, March 22
Precision Cancer Prevention at Dartmouth Cancer Center
Hear from an expert medical panel about groundbreaking developments happening around precision prevention and cancer care at Dartmouth Cancer Center.
Primary Care Providers and The Cancer Journey
A patient’s primary care provider (PCP) plays an important role in cancer prevention, screening and initial diagnosis, directed by guidelines and shared decision making.
Next-Generation Immunotherapy at Dartmouth Cancer Center
For 50 years, doctors and scientists at Dartmouth Cancer Center have been expanding the boundaries of cancer care, including breakthroughs in immunotherapy, that use the body’s own immune system to combat cancer.
Tyler J. Curiel, MD, MPH, FACP, selected as Victoria Hall Gmelich 1991 and Justin G. Gmelich Professorship in Cancer Immunotherapy
In this role, Curiel will provide visionary and expert leadership for the expansion of cancer immunotherapy research including in clinical trials.